Mutations in ASXL1 have been linked to inflammasome signaling, which aids in activating NLRP3-dependent pyroptosis in MDS (16). ASXL1 has been demonstrated to be involved in both innate immunological and inflammasome signaling (16). The gene discussed is NLRP3; the disease is myelodysplastic syndrome.